Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Crinetics Pharmaceuticals
company
About
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
- 101 - 250
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $3.20M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2008
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers. Their programs are derived from internal discovery efforts and use objective hormonal biomarker endpoints for preclinical and clinical studies to reduce both the risk and cost to achieve meaningful clinical data. Crinetics is seeking motivated partners to help advance Their programs to become commercially successful products.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
$108.90M
Crinetics Pharmaceuticals has raised a total of
$108.90M
in funding over 2 rounds. Their latest funding was raised on
Jun 21, 2018 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 21, 2018 | Grant | $3.20M | 1 |
National Institutes of Health
|
— | Detail |
| Mar 13, 2018 | Series B | $63.50M | 1 | — | — | Detail |
| Nov 2, 2015 | Series A | $40M | 1 | — | — | Detail |
| Sep 3, 2013 | Grant | $2.20M | 1 |
National Institutes of Health
|
— | Detail |
| Feb 7, 2009 | Grant | — | 1 |
National Institutes of Health
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
3
0
Crinetics Pharmaceuticals has made 3 investments. Their most recent investment was on
Jul 6, 2021, when Meati raised $50M.
Investors
Number of Lead Investors
Number of Investors
3
2
Crinetics Pharmaceuticals is funded by 2 investors.
National Institutes of Health
and Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Versant Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
